US 9018201
Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency
granted A61KA61K31/5025A61K31/5377
Quick answer
US patent 9018201 (Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/5025, A61K31/5377, A61K45/06, A61P